The speckle-type POZ protein (SPOP) was first cloned as a novel antigen from a scleroderma patient in 1997 [16], and was identified as an E3 ubiquitin-protein ligase that mediates ubiquitination and degradation of targeted proteins through proteasomal pathways [17–19]. The gene discussed is SPOP; the disease is scleroderma.